Form D · Venture Capital Fund

Biomatics Capital Partners II, L.P.

Seattle, WA · CIK 0001740118

Offering snapshot reported May 17, 2018 · SEC filing

Reported sold: Yet to sell
Investors reported: 0
Minimum accepted: $0
First sale: Yet to occur

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 17, 2018	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-312717

Source: Form D, filed May 17, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

BIOMATICS CAPITAL PARTNERS II, L.P

Investment adviser: BIOMATICS MANAGEMENT COMPANY, LLC

Gross asset value: $68M
Beneficial owners: 64
ADV minimum commitment: $0

Reported in Form ADV on May 14, 2024. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator STANDISH MANAGEMENT SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor FRANK, RIMERMAN & CO. SAN JOSE, California, United States

Custodian MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED NEW YORK, New York, United States Related to adviser: No

Custodian UBS SECURITIES LLC NEW YORK, New York, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

FRANK, RIMERMAN & CO.
PCAOB 1596

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
SEC 8-7221

UBS SECURITIES LLC
SEC 8-22651

Filing source

Form ADV 1876326 · May 14, 2024 · Schedule D 7.B.(1), fund 805-1855060052

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Related funds

Funds whose names form a numbered series with this one and that share its city or the name of a related person. Form D does not state how these funds are related.

Fund	Latest Form D	Reported sold	Investors
Biomatics Capital Partners, L.P.	Nov 17, 2016	$200,000,000	38
Biomatics Capital Partners II, L.P. (this fund)	May 17, 2018	Yet to sell	0

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Boris Nikolic	Executive
Julie Sunderland	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

719 Second Avenue, Suite 1402
Seattle, WA, 98104